Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Chiron Announces Change in Status of SEC Inquiry.


EMERYVILLE, Calif. -- Chiron Corporation (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:CHIR) announced today that the U.S. Securities and Exchange Commission (SEC) has issued a formal order of investigation with respect to potential violations of federal securities laws. The previously announced informal inquiry began following the suspension by the UK Medicines and Healthcare products Regulatory Agency The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK government agency which is responsible for ensuring that medicines and medical devices work and are acceptably safe.  (MHRA) of Chiron's license to manufacture FLUVIRIN(R) influenza virus vaccine influenza virus vaccine
n.
A vaccine containing influenza virus, usually several strains of the virus, prepared in chick embryos and used to immunize against influenza.
. Chiron is continuing to cooperate with the SEC's ongoing investigation.

Chiron does not undertake an obligation to update the information in this release.

About Chiron

Chiron delivers innovative and valuable products to protect human health by advancing pioneering science across the landscape of biotechnology. The company works to deliver on the limitless promise of science and make a positive difference in people's lives. For more information, please visit www.chiron.com.

About Chiron Vaccines

Chiron Vaccines, the world's fifth-largest vaccines business, is headquartered in Oxford, United Kingdom, and has facilities located throughout Europe, the United States and Asia. Chiron Vaccines is the world's second-largest manufacturer of influenza vaccines and has important meningitis, pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children.

pe·di·at·ric
adj.
Of or relating to pediatrics.
 and travel vaccine franchises. Chiron Vaccines is the leading vaccine manufacturer in the United Kingdom, Germany and Italy. The company's portfolio of products includes vaccines for influenza, meningitis C, rabies, tick-borne encephalitis, yellow fever, haemophilus influenzae B (Hib), polio, mumps, measles and rubella (MMR MMR measles-mumps-rubella (vaccine); see measles, mumps, and rubella vaccine live, under vaccine.

MMR
abbr.
measles, mumps, rubella vaccine
) and diphtheria, tetanus and pertussis pertussis: see whooping cough.  (whooping cough).

NOTE: FLUVIRIN is a trademark of Chiron Corporation.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 11, 2005
Words:234
Previous Article:A Romantic Dinner and 'I Love You' - Most Men Know What to Do for Valentine's Day.
Next Article:Constar International Inc. Completes $290 Million Refinancing.



Related Articles
Chiron and XOMA Form Collaboration for Development and Commercialization of Therapeutic Antibodies for Cancer.
BRIEFCASE DISNEY RELEASING MORE VIDEO GAMES.
XOMA and Chiron Announce Preclinical Data Presentations on CHIR-12.12 at American Hematology Conference.
Chiron and LabCorp Sign Licensing Agreement for Hepatitis C Plasma Testing; Agreement Further Expands Licensing of Chiron Technology.
Chiron Foundation Awards Five Grants to Emeryville and Oakland Community Organizations; Grants Reaffirm Foundation's Commitment to Enrich Lives in...
Chiron and XOMA Announce Initiation of Phase I Clinical Trial for CHIR-12.12 in Chronic Lymphocytic Leukemia; First Antibody Drug Candidate to Enter...
Chiron and XOMA Announce Initiation of Phase I Clinical Trial for CHIR-12.12 in Multiple Myeloma -- Second Clinical Trial Evaluating Oncology Drug...
BRIEFCASE.
Chiron Announces Termination of SEC Investigation.
Chiron Confirms Proposed Purchase of BETASERON Assets by Schering AG Under Change-in-Control Option.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles